Works matching IS 14783223 AND DT 2024 AND VI 44 AND IP 11

Results: 30
    1

    Reply to Yao et al.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 3098, doi. 10.1111/liv.16090
    By:
    • Zhang, Yan;
    • Gao, Yanxia;
    • Li, Yi
    Publication type:
    Article
    2

    Issue Information.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2869, doi. 10.1111/liv.16145
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 3060, doi. 10.1111/liv.16093
    By:
    • Tada, Toshifumi;
    • Kurosaki, Masayuki;
    • Toyoda, Hidenori;
    • Tamaki, Nobuharu;
    • Yasui, Yutaka;
    • Nakamura, Shinichiro;
    • Mori, Nami;
    • Tsuji, Keiji;
    • Ochi, Hironori;
    • Akahane, Takehiro;
    • Kobashi, Haruhiko;
    • Fujii, Hideki;
    • Marusawa, Hiroyuki;
    • Kondo, Masahiko;
    • Urawa, Naohito;
    • Yoshida, Hideo;
    • Uchida, Yasushi;
    • Morita, Atsuhiro;
    • Hasebe, Chitomi;
    • Mitsuda, Akeri
    Publication type:
    Article
    11
    12

    MicroRNAs modulate SARS‐CoV‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2983, doi. 10.1111/liv.16079
    By:
    • Khanal, Rajendra;
    • Heinen, Natalie;
    • Bogomolova, Alexandra;
    • Meister, Toni L.;
    • Herrmann, Simon T.;
    • Westhoven, Saskia;
    • Nocke, Maximilian K.;
    • Todt, Daniel;
    • Jockenhövel, Freya;
    • Klein, Isabel M.;
    • Hartmann, Laura;
    • Vondran, Florian W. R.;
    • Steinmann, Eike;
    • Zimmer, Gert;
    • Ott, Michael;
    • Brown, Richard J. P.;
    • Sharma, Amar Deep;
    • Pfaender, Stephanie
    Publication type:
    Article
    13
    14
    15

    Clinical outcomes of MAFLD versus NAFLD: A meta‐analysis of observational studies.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2939, doi. 10.1111/liv.16075
    By:
    • Pennisi, Grazia;
    • Infantino, Giuseppe;
    • Celsa, Ciro;
    • Di Maria, Gabriele;
    • Enea, Marco;
    • Vaccaro, Marco;
    • Cannella, Roberto;
    • Ciccioli, Carlo;
    • La Mantia, Claudia;
    • Mantovani, Alessandro;
    • Mercurio, Francesco;
    • Tilg, Herbert;
    • Targher, Giovanni;
    • Di Marco, Vito;
    • Cammà, Calogero;
    • Petta, Salvatore
    Publication type:
    Article
    16
    17
    18

    Response to Jui‐Ting Yu et al.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 3102, doi. 10.1111/liv.16073
    By:
    • Zhang, Qian;
    • Wu, Shan S.
    Publication type:
    Article
    19

    Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2950, doi. 10.1111/liv.16069
    By:
    • Xu, Kaiyu;
    • Kessler, Annika;
    • Nichetti, Federico;
    • Hoffmeister‐Wittmann, Paula;
    • Scherr, Anna‐Lena;
    • Nader, Luisa;
    • Kelmendi, Eblina;
    • Schmitt, Nathalie;
    • Schwab, Maximilian;
    • García‐Beccaria, María;
    • Sobol, Benjamin;
    • Nieto, Osama Azzam;
    • Isele, Hanna;
    • Gärtner, Ulrike;
    • Vaquero‐Siguero, Nuria;
    • Volk, Julia;
    • Korell, Felix;
    • Mock, Andreas;
    • Heide, Danijela;
    • Ramadori, Pierluigi
    Publication type:
    Article
    20
    21
    22

    What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2890, doi. 10.1111/liv.16064
    By:
    • Celsa, Ciro;
    • Rizzo, Giacomo E. M.;
    • Di Maria, Gabriele;
    • Enea, Marco;
    • Vaccaro, Marco;
    • Rancatore, Gabriele;
    • Graceffa, Pietro;
    • Falco, Giuseppe;
    • Petta, Salvatore;
    • Cabibbo, Giuseppe;
    • Calvaruso, Vincenza;
    • Craxì, Antonio;
    • Cammà, Calogero;
    • Di Marco, Vito;
    • Rizzo, Chiara;
    • Destro Castaniti, Giulia Maria;
    • Di Stefano, Vincenzo;
    • Madonia, Giorgio;
    • Tilotta, Giovanna;
    • Agliastro, Giuseppe
    Publication type:
    Article
    23

    Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2915, doi. 10.1111/liv.16063
    By:
    • Marciano, Sebastián;
    • Piano, Salvatore;
    • Singh, Virendra;
    • Caraceni, Paolo;
    • Maiwall, Rakhi;
    • Alessandria, Carlo;
    • Fernandez, Javier;
    • Kim, Dong Joon;
    • Kim, Sung Eun;
    • Soares, Elza;
    • Marino, Mónica;
    • Vorobioff, Julio;
    • Merli, Manuela;
    • Elkrief, Laure;
    • Vargas, Victor;
    • Krag, Aleksander;
    • Singh, Shivaram;
    • Elizondo, Martín;
    • Anders, Maria M;
    • Dirchwolf, Melisa
    Publication type:
    Article
    24

    High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 2904, doi. 10.1111/liv.16056
    By:
    • Schwarz, Michael;
    • Simbrunner, Benedikt;
    • Jachs, Mathias;
    • Hartl, Lukas;
    • Balcar, Lorenz;
    • Bauer, David J. M.;
    • Semmler, Georg;
    • Hofer, Benedikt S.;
    • Scheiner, Bernhard;
    • Pinter, Matthias;
    • Stättermayer, Albert F.;
    • Trauner, Michael;
    • Reiberger, Thomas;
    • Mandorfer, Mattias
    Publication type:
    Article
    25
    26
    27
    28

    CTX‐III in hepatitis C.

    Published in:
    Liver International, 2024, v. 44, n. 11, p. 3108, doi. 10.1111/liv.16041
    By:
    • Laursen, Tea L.;
    • Kjær, Mikkel B.;
    • Leeming, Diana J.;
    • Grønbæk, Henning
    Publication type:
    Article
    29
    30